Lexicon Pharmaceuticals Announced Plans For $95 Million Common Stock Offering

Lexicon Pharmaceuticals (NASDAQ:LXRX) announced that it is offering to sell $95 million of its common stock in an underwritten public offering.

The company plans to grant underwriters a 30-day option to purchase up to an additional $14.25 million of common stock to cover over-allotments.

Morgan Stanley (NYSE:MS) and JP Morgan (NYSE:JPM) will be acting as joint book-runners for the offering. Cowen and Company and Thomas Weisel Partners will be acting as co-managers.